Product
JointStem
1 clinical trial
2 indications
Indication
OsteoarthritisIndication
KneeClinical trial
A 48-Weeks, Phase 2b/3a, Double-Blind, Randomized, Placebo Controlled, Multi-center, Superiority Study to Evaluate the Efficacy and Safety of JointStem, Autologous Adipose Tissue Derived Mesenchymal Stem Cells in Patients Diagnosed as Knee OsteoarthritisStatus: Recruiting, Estimated PCD: 2024-06-30